SOLIGENIX, INC. Increase (Decrease) in Other Employee-Related Liabilities
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Other Employee-Related Liabilities of -$404.07 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities · last filed 2026-08-07
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for the quarter ending 2026-06-30 was $41.05K, a 12.00% increase year-over-year.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for the quarter ending 2026-03-31 was -$445.12K.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for the quarter ending 2025-12-31 was $415.31K, a 64.75% increase year-over-year.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for the quarter ending 2025-09-30 was -$14.37K, a 448.96% decline year-over-year.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for fiscal 2025 was $151.68K, a 77.77% increase from fiscal 2024.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for fiscal 2024 was $85.33K.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for fiscal 2023 was -$85.58K, a 353.52% decline from fiscal 2022.
- SOLIGENIX, INC. increase (decrease) in other employee-related liabilities for fiscal 2022 was $33.76K.
| Period end | Increase (Decrease) in Other Employee-Related Liabilities 3 month | Increase (Decrease) in Other Employee-Related Liabilities 6 month | Increase (Decrease) in Other Employee-Related Liabilities 9 month | Increase (Decrease) in Other Employee-Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$404.07K 10-Q · filed 2026-08-07 | $11.23K derived: sum of 3 quarters · filed 2026-08-07 | -$3.14K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$445.12K 10-Q · filed 2026-05-08 | -$29.82K derived: sum of 2 quarters · filed 2026-05-08 | -$44.19K derived: sum of 3 quarters · filed 2026-05-08 | -$7.54K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $415.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $400.94K derived: sum of 2 quarters · filed 2026-03-31 | $437.59K derived: sum of 3 quarters · filed 2026-08-07 | $151.68K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$14.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $22.28K derived: sum of 2 quarters · filed 2026-08-07 | -$263.62K 10-Q · filed 2025-11-07 | -$11.54K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $36.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$249.25K 10-Q · filed 2026-08-07 | $2.83K derived: sum of 3 quarters · filed 2026-08-07 | $6.95K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$285.90K 10-Q · filed 2026-05-08 | -$33.83K derived: sum of 2 quarters · filed 2026-05-08 | -$29.71K derived: sum of 3 quarters · filed 2026-05-08 | $321.00 derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $252.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $256.20K derived: sum of 2 quarters · filed 2026-03-31 | $286.23K derived: sum of 3 quarters · filed 2026-03-31 | $85.33K 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $34.15K derived: sum of 2 quarters · filed 2025-11-07 | -$166.75K 10-Q · filed 2025-11-07 | $28.82K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $30.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$170.87K 10-Q · filed 2025-08-14 | $24.70K derived: sum of 3 quarters · filed 2025-08-14 | $6.38K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$200.90K 10-Q · filed 2025-05-09 | -$5.33K derived: sum of 2 quarters · filed 2025-05-09 | -$23.64K derived: sum of 3 quarters · filed 2025-05-09 | $5.72K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $195.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $177.25K derived: sum of 2 quarters · filed 2025-03-21 | $206.62K derived: sum of 3 quarters · filed 2025-03-21 | -$85.58K 10-K · filed 2025-03-21 |
| 2023-09-30 | -$18.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $11.05K derived: sum of 2 quarters · filed 2024-11-08 | -$281.15K 10-Q · filed 2024-11-08 | -$4.25K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $29.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$262.83K 10-Q · filed 2024-08-09 | $14.07K derived: sum of 3 quarters · filed 2024-08-09 | $16.10K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$292.20K 10-Q · filed 2024-05-10 | -$15.30K derived: sum of 2 quarters · filed 2024-05-10 | -$13.27K derived: sum of 3 quarters · filed 2024-05-10 | $6.44K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $276.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $278.93K derived: sum of 2 quarters · filed 2024-03-15 | $298.64K derived: sum of 3 quarters · filed 2024-03-15 | $33.76K 10-K · filed 2024-03-15 |
| 2022-09-30 | $2.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $21.74K derived: sum of 2 quarters · filed 2023-11-13 | -$243.15K 10-Q · filed 2023-11-13 | $1.06K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $19.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$245.17K 10-Q · filed 2023-08-21 | -$967.00 derived: sum of 3 quarters · filed 2023-08-21 | -$9.29K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | -$264.89K 10-Q · filed 2023-05-15 | -$20.68K derived: sum of 2 quarters · filed 2023-05-15 | -$29.00K derived: sum of 3 quarters · filed 2023-05-15 | -$8.57K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $244.21K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $235.88K derived: sum of 2 quarters · filed 2023-03-31 | $256.31K derived: sum of 3 quarters · filed 2023-03-31 | -$572.16K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$8.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $12.10K derived: sum of 2 quarters · filed 2022-11-10 | -$816.37K 10-Q · filed 2022-11-10 | -$15.30K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $20.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$808.04K 10-Q · filed 2022-08-12 | -$6.97K derived: sum of 3 quarters · filed 2022-08-12 | -$9.61K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$828.47K 10-Q · filed 2022-05-13 | -$27.40K derived: sum of 2 quarters · filed 2022-05-13 | -$30.04K derived: sum of 3 quarters · filed 2022-05-13 | $2.94K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $801.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $798.44K derived: sum of 2 quarters · filed 2022-03-29 | $831.41K derived: sum of 3 quarters · filed 2022-03-29 | $576.92K 10-K · filed 2022-03-29 |
| 2020-09-30 | -$2.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $30.34K derived: sum of 2 quarters · filed 2021-11-12 | -$224.15K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $32.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$221.51K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$254.48K 10-Q · filed 2021-05-18 | |||
| 2019-12-31 | $3.54K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |